1. P197 A multinational, prospective, observational study in patients with rheumatoid arthritis receiving baricitinib, targeted synthetic or biologic disease-modifying therapies: 6-month effectiveness and patient-reported outcome data from the European cohort. (23rd April 2022) Authors: Kiprianos, Allan; Alten, Rieke; Burmester, Gerd; Matucci-Cerinic, Marco; Salmon, Jean-Hugues; Lopez-Romero, Pedro; Fakhouri, Walid; de la Torre, Inmaculada; Gentzel-Jorczyk, Anja; Holzkämper, Thorsten; Fautrel, Bruno Journal: Rheumatology Issue: Volume 61(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗